These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Aprotinin does not inhibit the release of PGI2 or vWF from cultured human endothelial cells. Royston BD; Royston D; Coade SB; Morgan DM; Pearson JD Thromb Haemost; 1992 Jan; 67(1):172-5. PubMed ID: 1377415 [TBL] [Abstract][Full Text] [Related]
3. Assessment of the antiplatelet effects of low to medium dose aspirin in the early and late phases after ischaemic stroke and TIA. McCabe DJ; Harrison P; Mackie IJ; Sidhu PS; Lawrie AS; Purdy G; Machin SJ; Brown MM Platelets; 2005 Aug; 16(5):269-80. PubMed ID: 16011977 [TBL] [Abstract][Full Text] [Related]
5. In vitro studies of thromboresistance: the role of prostacyclin (PGI2) in platelet adhesion to cultured normal and virally transformed human vascular endothelial cells. Curwen KD; Gimbrone MA; Handin RI Lab Invest; 1980 Mar; 42(3):366-74. PubMed ID: 6244462 [TBL] [Abstract][Full Text] [Related]
6. Adenosine 3':5'-cyclic monophosphate induces regulated secretion of tissue-type plasminogen activator and von Willebrand factor from cultured human endothelial cells. Hegeman RJ; van den Eijnden-Schrauwen Y; Emeis JJ Thromb Haemost; 1998 Apr; 79(4):853-8. PubMed ID: 9569204 [TBL] [Abstract][Full Text] [Related]
7. Endothelial cell seeding on crosslinked collagen: effects of crosslinking on endothelial cell proliferation and functional parameters. Wissink MJ; van Luyn MJ; Beernink R; Dijk F; Poot AA; Engbers GH; Beugeling T; van Aken WG; Feijen J Thromb Haemost; 2000 Aug; 84(2):325-31. PubMed ID: 10959708 [TBL] [Abstract][Full Text] [Related]
8. Nitric oxide complements prostacyclin in the regulation of endothelial thromboresistance under flow conditions. Korbut R; Ocetkiewicz A; Gryglewski RJ Methods Find Exp Clin Pharmacol; 1993 Apr; 15(3):179-81. PubMed ID: 8332034 [TBL] [Abstract][Full Text] [Related]
9. Formation by the endothelium of prostacyclin, nitric oxide and endothelin. Vane JR; Botting RM J Lipid Mediat; 1993; 6(1-3):395-404. PubMed ID: 8357997 [TBL] [Abstract][Full Text] [Related]
10. Nitric oxide as a regulator of prostacyclin synthesis in cultured rat heart endothelial cells. Sievi E; Lähteenmäki TA; Alanko J; Vuorinen P; Vapaatalo H Arzneimittelforschung; 1997 Oct; 47(10):1093-8. PubMed ID: 9368700 [TBL] [Abstract][Full Text] [Related]
11. Acute von Willebrand factor secretion from the endothelium in vivo: assessment through plasma propeptide (vWf:AgII) Levels. Vischer UM; Ingerslev J; Wollheim CB; Mestries JC; Tsakiris DA; Haefeli WE; Kruithof EK Thromb Haemost; 1997 Feb; 77(2):387-93. PubMed ID: 9157601 [TBL] [Abstract][Full Text] [Related]
12. Inhibition by nitric oxide-releasing compounds of prostacyclin production in human endothelial cells. Kosonen O; Kankaanranta H; Malo-Ranta U; Ristimäki A; Moilanen E Br J Pharmacol; 1998 Sep; 125(2):247-54. PubMed ID: 9786495 [TBL] [Abstract][Full Text] [Related]
13. Losac, a factor X activator from Lonomia obliqua bristle extract: its role in the pathophysiological mechanisms and cell survival. Alvarez Flores MP; Fritzen M; Reis CV; Chudzinski-Tavassi AM Biochem Biophys Res Commun; 2006 May; 343(4):1216-23. PubMed ID: 16597435 [TBL] [Abstract][Full Text] [Related]
14. Role of nitric oxide synthase and cyclooxygenase in hyperdynamic splanchnic circulation of portal hypertension. Xu J; Cao H; Liu H; Wu ZY Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):503-8. PubMed ID: 18842497 [TBL] [Abstract][Full Text] [Related]
15. Endothelial prostaglandin and nitric oxide synthesis in atherogenesis and thrombosis. Wu KK J Formos Med Assoc; 1996 Sep; 95(9):661-6. PubMed ID: 8918053 [TBL] [Abstract][Full Text] [Related]
16. Endothelial cells play an important role in the antiaggregatory effect of nitric oxide. Klinge JM; Topf HG; Trusen B; Rauh M; Rascher W; Dötsch J Crit Care Med; 2003 Jul; 31(7):2010-4. PubMed ID: 12847397 [TBL] [Abstract][Full Text] [Related]
17. Dual functionality of cyclooxygenase-2 as a regulator of tumor necrosis factor-mediated G1 shortening and nitric oxide-mediated inhibition of vascular smooth muscle cell proliferation. Haider A; Lee I; Grabarek J; Darzynkiewicz Z; Ferreri NR Circulation; 2003 Aug; 108(8):1015-21. PubMed ID: 12912810 [TBL] [Abstract][Full Text] [Related]
18. Systemic clotting activation by low-grade endotoxaemia in liver cirrhosis: a potential role for endothelial procoagulant activation. Ferro D; Basili S; Lattuada A; Mantovani B; Bellomo A; Mannucci PM; Violi F Ital J Gastroenterol Hepatol; 1997 Oct; 29(5):434-40. PubMed ID: 9494853 [TBL] [Abstract][Full Text] [Related]
19. Secretory function of vascular endothelium and its implication in the action of vasoactive drugs. Gryglewski RJ Pol J Pharmacol Pharm; 1990; 42(3):219-36. PubMed ID: 2263533 [TBL] [Abstract][Full Text] [Related]
20. Modulation of nitric oxide and 6-keto-prostaglandin F(1alpha) production in bovine aortic endothelial cells by conjugated linoleic acid. Coen P; Cummins P; Birney Y; Devery R; Cahill P Endothelium; 2004; 11(3-4):211-20. PubMed ID: 15370299 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]